Voya Investment Management LLC Arcutis Biotherapeutics, Inc. Transaction History

Voya Investment Management LLC

$78.9 Billion
Q4 2024

A detailed history of Voya Investment Management LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 32,136 shares of ARQT stock, worth $495,215. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,136

Previous 34,608 7.14%

Holding current value

$495,215

Previous $321,000 39.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.31 - $14.99 $20,542 - $37,055	-2,472 Reduced 7.14%	32,136 $447,000
Q3 2024 Feb 07, 2025	SELL	$8.32 - $11.0 $6,705 - $8,866	-806 Reduced 2.28%	34,608 $321,000
Q3 2024 Nov 14, 2024	SELL	$8.32 - $11.0 $6,705 - $8,866	-806 Reduced 2.28%	34,608 $321,000
Q2 2024 Feb 07, 2025	BUY	$7.24 - $12.53 $67,027 - $116,002	9,258 Added 35.4%	35,414 $329,000
Q2 2024 Dec 03, 2024	BUY	$7.24 - $12.53 $5,835 - $10,099	806 Added 2.33%	35,414 $329,000
Q2 2024 Aug 14, 2024	BUY	$7.24 - $12.53 $67,027 - $116,002	9,258 Added 35.4%	35,414 $329,000
Q1 2024 Feb 07, 2025	SELL	$3.25 - $11.77 $27,469 - $99,480	-8,452 Reduced 24.42%	26,156 $259,000
Q1 2024 Dec 06, 2024	SELL	$3.25 - $11.77 $27,469 - $99,480	-8,452 Reduced 24.42%	26,156 $259,000
Q1 2024 May 15, 2024	SELL	$3.25 - $11.77 $217,932 - $789,249	-67,056 Reduced 71.94%	26,156 $259,000
Q4 2023 Feb 07, 2025	BUY	$1.84 - $4.82 $101,071 - $264,762	54,930 Added 143.49%	93,212 $301,000
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $101,071 - $264,762	54,930 Added 143.49%	93,212 $301,000
Q3 2023 Feb 07, 2025	BUY	$5.31 - $10.98 $3,754 - $7,762	707 Added 1.88%	38,282 $203,000
Q3 2023 Nov 14, 2023	BUY	$5.31 - $10.98 $3,754 - $7,762	707 Added 1.88%	38,282 $203,000
Q2 2023 Feb 07, 2025	BUY	$7.51 - $15.0 $37,129 - $74,160	4,944 Added 15.15%	37,575 $358,000
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $37,129 - $74,160	4,944 Added 15.15%	37,575 $358,000
Q1 2023 Feb 07, 2025	SELL	$10.23 - $17.14 $20,224 - $33,885	-1,977 Reduced 5.71%	32,631 $358,000
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $28,030 - $46,963	-2,740 Reduced 7.75%	32,631 $358,000
Q3 2022 Feb 07, 2025	BUY	$17.85 - $26.95 $13,619 - $20,562	763 Added 2.2%	35,371 $675,000
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $397,091 - $599,529	22,246 Added 169.49%	35,371 $676,000
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $38,947 - $52,947	2,385 Added 22.21%	13,125 $280,000
Q4 2021 Feb 14, 2022	SELL	$14.98 - $25.5 $584 - $994	-39 Reduced 0.36%	10,740 $223,000
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $32,796 - $46,669	1,343 Added 14.23%	10,779 $294,000
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $24,543 - $37,090	1,003 Added 11.89%	9,436 $273,000
Q4 2020 Feb 16, 2021	BUY	$17.82 - $31.73 $150,276 - $267,579	8,433 New	8,433 $237,000

Others Institutions Holding ARQT

# of Institutions

228

Shares Held

129M

Call Options Held

2.02M

Put Options Held

202K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $927M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Arcutis Biotherapeutics, Inc. Transaction History